Romel Rosales

7PUBLICATIONS
223CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCheminformatics and quantitative structure-activity relationshipsGene and molecular therapyProteins and peptidesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 09, 2023
Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection.

Jin Wei, Ajinkya Patil, Clayton K Collings

|Dec 23, 2022
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules.

Alvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales

|Jun 29, 2022
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.

Marie O Pohl, Laura Martin-Sancho, Ranjala Ratnayake

|Oct 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.

Britton Boras, Rhys M Jones, Brandon J Anson

|Jul 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.

Tia A Tummino, Veronica V Rezelj, Benoit Fischer

|Jan 26, 2021
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.

Kris M White, Romel Rosales, Soner Yildiz

Pageof 2